Skip to main content
. 2020 Jul 29;14(7):e0008548. doi: 10.1371/journal.pntd.0008548

Fig 1. Estimated timelines of coronavirus RBDs as COVID-19 vaccines.

Fig 1

cGMP, current good manufacturing practices; RBD, receptor-binding domain.